Amniocentesis Needles Market Top Players and Strategies

-
According to research report the amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 150.6 million in 2017, at a CAGR of 2.8%. Factors driving the growth of this market include the high reliability of amniocentesis, increase in the median age of first-time motherhood, and heavy burden of congenital disorders.
The amniocentesis needles market is consolidated in nature due to the presence of a large number of players. The key players in the market are Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).
The key strategy followed by most companies in the amniocentesis needles market is acquisitions. This strategy accounted for the largest share of the overall growth strategies mapped from 2014 to 2017. Some of the leading players who adopted this strategy include Medtronic (Ireland), BD (US), CooperSurgical (US), and Medline (US).
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18541768
Medtronic held the leading position in the amniocentesis needles market in 2016. The company operates in the US, non-US developed countries, and emerging countries. The company offers amniocentesis needles through the patient monitoring & recovery subdivision of the minimally invasive therapy segment. The company acquired Covidien with a view to combine the innovations and extensive capabilities of both companies. However, in 2017, as part of restructuring, the company sold three product lines to Cardinal Health and amniocentesis needles was a part of one of the above product lines.
CooperSurgical ranked second in the amniocentesis needles market in 2016. The company focuses on a broad portfolio of products and services which are focused on women's health, fertility, and diagnostics. The amniocentesis needles are offered through the Wallace brand which it acquired from Smiths Medical in 2016 for USD 168 million. The company manufactures its products in the US, Germany, the Netherlands, and Denmark. It distributes its products across the globe through a network of distributors.
Know more: https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html

Major Market Developments
·         In 2018, Medline Industries, Inc. (US) completed the acquisition of  Centurion Medical Products (US) to provide a complete set of offerings that complement its minor procedure tray kits and its growing infection prevention focus
·         In 2016, CooperSurgical (US) completed the acquisition of Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc, to strengthen product portfolio and takeover premier products for women’s health
·         In 2017, Medtronic established an innovation center in Chengdu, China to provide advanced training to medical workers in Central and Western China
·         In 2016, Medline shifted its corporate headquarters to a new, state-of-the-art facility which is more than double the size of its current space with a view to adapt to the needs of the rapidly changing healthcare.


Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more